Categories AlphaGraphs, Consumer, Earnings
JNJ Earnings: Johnson & Johnson reports higher sales and adj. profit for Q2
Johnson & Johnson (NYSE: JNJ) reported an increase in sales and adjusted profit for the second quarter of 2022 when strong performance by the core pharmaceuticals segment more than offset lower sales in the other operating divisions. The pharma giant’s shares made modest gains early Tuesday following the announcement.
Net sales increased 3% year-over-year to $24.0 billion during the second quarter, reflecting the strength and resilience of the company’s market leadership in the midst of macroeconomic challenges.
Second-quarter adjusted earnings moved up to $2.59 per share from $2.48 per share in the prior-year period. Unadjusted profit was $4.81 billion or $1.80 per share, compared to $6.28 billion or $2.35 per share a year earlier.
Check this space to read management/analysts’ comments on Johnson & Johnson’s Q2 2022 earnings
“Our solid second quarter results across Johnson & Johnson reflect the strength and resilience of our Company’s market leadership in the midst of macroeconomic challenges,” said Joaquin Duato, chief executive officer of Johnson & Johnson.
Prior Performance
Most Popular
CAT Stock: Here’s what you need to know before investing in Caterpillar
After beating the virus-induced slowdown, excavator company Caterpillar Inc. (NYSE: CAT) is currently battling high operating costs and supply constraints that offset benefits of the demand recovery spurred by market
eBay (EBAY): A look at this ecommerce company’s expectations for the rest of the year
Shares of eBay Inc. (NASDAQ: EBAY) were up over 1% on Friday. The stock has dropped 25% year-to-date and 33% over the past 12 months. Last week, the company delivered
Stock Watch: Why General Motors (GM) is a good buy after earnings
When the COVID crisis battered the business world a couple of years ago, General Motors Company (NYSE: GM) was not spared, though the impact was not as big as initially
